Already a Bloomberg.com user?
Sign in with the same account.
Teva Pharmaceutical Industries Ltd. (TEVA) declined to the lowest in almost a week, closing the gap with the U.S.-traded shares of the world’s largest generic drugmaker.
Shares of Teva declined 2.3 percent to 155.30 shekels, or the equivalent of $39.52, the weakest intraday level since June 21, at 10:19 a.m. in Tel Aviv. The American depositary receipts of Petach Tikva, Israel-based Teva closed at $39.72 yesterday.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org